|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CDK9-CDK9 (FusionGDB2 ID:15320) |
Fusion Gene Summary for CDK9-CDK9 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CDK9-CDK9 | Fusion gene ID: 15320 | Hgene | Tgene | Gene symbol | CDK9 | CDK9 | Gene ID | 1025 | 1025 |
| Gene name | cyclin dependent kinase 9 | cyclin dependent kinase 9 | |
| Synonyms | C-2k|CDC2L4|CTK1|PITALRE|TAK | C-2k|CDC2L4|CTK1|PITALRE|TAK | |
| Cytomap | 9q34.11 | 9q34.11 | |
| Type of gene | protein-coding | protein-coding | |
| Description | cyclin-dependent kinase 9CDC2-related kinasecell division cycle 2-like protein kinase 4cell division protein kinase 9serine/threonine protein kinase PITALREtat-associated kinase complex catalytic subunit | cyclin-dependent kinase 9CDC2-related kinasecell division cycle 2-like protein kinase 4cell division protein kinase 9serine/threonine protein kinase PITALREtat-associated kinase complex catalytic subunit | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P50750 | P50750 | |
| Ensembl transtripts involved in fusion gene | ENST00000373264, ENST00000373265, ENST00000480353, | ENST00000373264, ENST00000373265, ENST00000480353, | |
| Fusion gene scores | * DoF score | 1 X 2 X 1=2 | 2 X 3 X 1=6 |
| # samples | 2 | 3 | |
| ** MAII score | log2(2/2*10)=3.32192809488736 | log2(3/6*10)=2.32192809488736 | |
| Context | PubMed: CDK9 [Title/Abstract] AND CDK9 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | CDK9(130552230)-CDK9(130552082), # samples:1 CDK9(130552004)-CDK9(130552084), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CDK9 | GO:0006282 | regulation of DNA repair | 20493174 |
| Hgene | CDK9 | GO:0006468 | protein phosphorylation | 16109376 |
| Hgene | CDK9 | GO:0031056 | regulation of histone modification | 19844166 |
| Hgene | CDK9 | GO:0031297 | replication fork processing | 20930849 |
| Hgene | CDK9 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 28426094 |
| Hgene | CDK9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 28426094 |
| Hgene | CDK9 | GO:0071157 | negative regulation of cell cycle arrest | 20930849 |
| Hgene | CDK9 | GO:0071345 | cellular response to cytokine stimulus | 17956865 |
| Hgene | CDK9 | GO:1903839 | positive regulation of mRNA 3'-UTR binding | 19575011 |
| Tgene | CDK9 | GO:0006282 | regulation of DNA repair | 20493174 |
| Tgene | CDK9 | GO:0006468 | protein phosphorylation | 16109376 |
| Tgene | CDK9 | GO:0031056 | regulation of histone modification | 19844166 |
| Tgene | CDK9 | GO:0031297 | replication fork processing | 20930849 |
| Tgene | CDK9 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 28426094 |
| Tgene | CDK9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 28426094 |
| Tgene | CDK9 | GO:0071157 | negative regulation of cell cycle arrest | 20930849 |
| Tgene | CDK9 | GO:0071345 | cellular response to cytokine stimulus | 17956865 |
| Tgene | CDK9 | GO:1903839 | positive regulation of mRNA 3'-UTR binding | 19575011 |
| Fusion gene breakpoints across CDK9 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across CDK9 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS5.0 | N/A | BF751344 | CDK9 | chr9 | 130552230 | - | CDK9 | chr9 | 130552082 | + |
| ChiTaRS5.0 | N/A | BI024596 | CDK9 | chr9 | 130552004 | - | CDK9 | chr9 | 130552084 | + |
Top |
Fusion Gene ORF analysis for CDK9-CDK9 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 3UTR-3UTR | ENST00000373264 | ENST00000373264 | CDK9 | chr9 | 130552230 | - | CDK9 | chr9 | 130552082 | + |
| 3UTR-3UTR | ENST00000373264 | ENST00000373264 | CDK9 | chr9 | 130552004 | - | CDK9 | chr9 | 130552084 | + |
| 3UTR-3UTR | ENST00000373264 | ENST00000373265 | CDK9 | chr9 | 130552230 | - | CDK9 | chr9 | 130552082 | + |
| 3UTR-3UTR | ENST00000373264 | ENST00000373265 | CDK9 | chr9 | 130552004 | - | CDK9 | chr9 | 130552084 | + |
| 3UTR-3UTR | ENST00000373265 | ENST00000373264 | CDK9 | chr9 | 130552230 | - | CDK9 | chr9 | 130552082 | + |
| 3UTR-3UTR | ENST00000373265 | ENST00000373264 | CDK9 | chr9 | 130552004 | - | CDK9 | chr9 | 130552084 | + |
| 3UTR-3UTR | ENST00000373265 | ENST00000373265 | CDK9 | chr9 | 130552230 | - | CDK9 | chr9 | 130552082 | + |
| 3UTR-3UTR | ENST00000373265 | ENST00000373265 | CDK9 | chr9 | 130552004 | - | CDK9 | chr9 | 130552084 | + |
| 3UTR-intron | ENST00000373264 | ENST00000480353 | CDK9 | chr9 | 130552230 | - | CDK9 | chr9 | 130552082 | + |
| 3UTR-intron | ENST00000373264 | ENST00000480353 | CDK9 | chr9 | 130552004 | - | CDK9 | chr9 | 130552084 | + |
| 3UTR-intron | ENST00000373265 | ENST00000480353 | CDK9 | chr9 | 130552230 | - | CDK9 | chr9 | 130552082 | + |
| 3UTR-intron | ENST00000373265 | ENST00000480353 | CDK9 | chr9 | 130552004 | - | CDK9 | chr9 | 130552084 | + |
| intron-3UTR | ENST00000480353 | ENST00000373264 | CDK9 | chr9 | 130552230 | - | CDK9 | chr9 | 130552082 | + |
| intron-3UTR | ENST00000480353 | ENST00000373264 | CDK9 | chr9 | 130552004 | - | CDK9 | chr9 | 130552084 | + |
| intron-3UTR | ENST00000480353 | ENST00000373265 | CDK9 | chr9 | 130552230 | - | CDK9 | chr9 | 130552082 | + |
| intron-3UTR | ENST00000480353 | ENST00000373265 | CDK9 | chr9 | 130552004 | - | CDK9 | chr9 | 130552084 | + |
| intron-intron | ENST00000480353 | ENST00000480353 | CDK9 | chr9 | 130552230 | - | CDK9 | chr9 | 130552082 | + |
| intron-intron | ENST00000480353 | ENST00000480353 | CDK9 | chr9 | 130552004 | - | CDK9 | chr9 | 130552084 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for CDK9-CDK9 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CDK9-CDK9 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:130552230/:130552082) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CDK9 | CDK9 |
| FUNCTION: Protein kinase involved in the regulation of transcription (PubMed:10574912, PubMed:10757782, PubMed:11145967, PubMed:11575923, PubMed:11809800, PubMed:11884399, PubMed:14701750, PubMed:16109376, PubMed:16109377, PubMed:20930849, PubMed:28426094). Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP (PubMed:10574912, PubMed:10757782, PubMed:11145967, PubMed:11575923, PubMed:11809800, PubMed:11884399, PubMed:14701750, PubMed:16109376, PubMed:16109377, PubMed:20930849, PubMed:28426094). This complex is inactive when in the 7SK snRNP complex form (PubMed:10574912, PubMed:10757782, PubMed:11145967, PubMed:11575923, PubMed:11809800, PubMed:11884399, PubMed:14701750, PubMed:16109376, PubMed:16109377, PubMed:20930849, PubMed:28426094). Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR and the negative elongation factors DSIF and NELF (PubMed:9857195, PubMed:10912001, PubMed:11112772, PubMed:12037670, PubMed:20081228, PubMed:20980437, PubMed:21127351). Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling) (PubMed:17956865, PubMed:18362169). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis (PubMed:10393184, PubMed:11112772). P-TEFb is also involved in cotranscriptional histone modification, mRNA processing and mRNA export (PubMed:15564463, PubMed:19575011, PubMed:19844166). Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3; integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing (PubMed:15564463, PubMed:19575011, PubMed:19844166). The CDK9/cyclin-K complex has also a kinase activity towards CTD of RNAP II and can substitute for CDK9/cyclin-T P-TEFb in vitro (PubMed:21127351). Replication stress response protein; the CDK9/cyclin-K complex is required for genome integrity maintenance, by promoting cell cycle recovery from replication arrest and limiting single-stranded DNA amount in response to replication stress, thus reducing the breakdown of stalled replication forks and avoiding DNA damage (PubMed:20493174). In addition, probable function in DNA repair of isoform 2 via interaction with KU70/XRCC6 (PubMed:20493174). Promotes cardiac myocyte enlargement (PubMed:20081228). RPB1/POLR2A phosphorylation on 'Ser-2' in CTD activates transcription (PubMed:21127351). AR phosphorylation modulates AR transcription factor promoter selectivity and cell growth. DSIF and NELF phosphorylation promotes transcription by inhibiting their negative effect (PubMed:9857195, PubMed:10912001, PubMed:11112772). The phosphorylation of MYOD1 enhances its transcriptional activity and thus promotes muscle differentiation (PubMed:12037670). {ECO:0000269|PubMed:10393184, ECO:0000269|PubMed:10574912, ECO:0000269|PubMed:10757782, ECO:0000269|PubMed:10912001, ECO:0000269|PubMed:11112772, ECO:0000269|PubMed:11145967, ECO:0000269|PubMed:11575923, ECO:0000269|PubMed:11809800, ECO:0000269|PubMed:11884399, ECO:0000269|PubMed:12037670, ECO:0000269|PubMed:14701750, ECO:0000269|PubMed:15564463, ECO:0000269|PubMed:16109376, ECO:0000269|PubMed:16109377, ECO:0000269|PubMed:17956865, ECO:0000269|PubMed:18362169, ECO:0000269|PubMed:19575011, ECO:0000269|PubMed:19844166, ECO:0000269|PubMed:20081228, ECO:0000269|PubMed:20493174, ECO:0000269|PubMed:20930849, ECO:0000269|PubMed:20980437, ECO:0000269|PubMed:21127351, ECO:0000269|PubMed:28426094, ECO:0000269|PubMed:9857195}. | FUNCTION: Protein kinase involved in the regulation of transcription (PubMed:10574912, PubMed:10757782, PubMed:11145967, PubMed:11575923, PubMed:11809800, PubMed:11884399, PubMed:14701750, PubMed:16109376, PubMed:16109377, PubMed:20930849, PubMed:28426094). Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP (PubMed:10574912, PubMed:10757782, PubMed:11145967, PubMed:11575923, PubMed:11809800, PubMed:11884399, PubMed:14701750, PubMed:16109376, PubMed:16109377, PubMed:20930849, PubMed:28426094). This complex is inactive when in the 7SK snRNP complex form (PubMed:10574912, PubMed:10757782, PubMed:11145967, PubMed:11575923, PubMed:11809800, PubMed:11884399, PubMed:14701750, PubMed:16109376, PubMed:16109377, PubMed:20930849, PubMed:28426094). Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR and the negative elongation factors DSIF and NELF (PubMed:9857195, PubMed:10912001, PubMed:11112772, PubMed:12037670, PubMed:20081228, PubMed:20980437, PubMed:21127351). Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling) (PubMed:17956865, PubMed:18362169). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis (PubMed:10393184, PubMed:11112772). P-TEFb is also involved in cotranscriptional histone modification, mRNA processing and mRNA export (PubMed:15564463, PubMed:19575011, PubMed:19844166). Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3; integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing (PubMed:15564463, PubMed:19575011, PubMed:19844166). The CDK9/cyclin-K complex has also a kinase activity towards CTD of RNAP II and can substitute for CDK9/cyclin-T P-TEFb in vitro (PubMed:21127351). Replication stress response protein; the CDK9/cyclin-K complex is required for genome integrity maintenance, by promoting cell cycle recovery from replication arrest and limiting single-stranded DNA amount in response to replication stress, thus reducing the breakdown of stalled replication forks and avoiding DNA damage (PubMed:20493174). In addition, probable function in DNA repair of isoform 2 via interaction with KU70/XRCC6 (PubMed:20493174). Promotes cardiac myocyte enlargement (PubMed:20081228). RPB1/POLR2A phosphorylation on 'Ser-2' in CTD activates transcription (PubMed:21127351). AR phosphorylation modulates AR transcription factor promoter selectivity and cell growth. DSIF and NELF phosphorylation promotes transcription by inhibiting their negative effect (PubMed:9857195, PubMed:10912001, PubMed:11112772). The phosphorylation of MYOD1 enhances its transcriptional activity and thus promotes muscle differentiation (PubMed:12037670). {ECO:0000269|PubMed:10393184, ECO:0000269|PubMed:10574912, ECO:0000269|PubMed:10757782, ECO:0000269|PubMed:10912001, ECO:0000269|PubMed:11112772, ECO:0000269|PubMed:11145967, ECO:0000269|PubMed:11575923, ECO:0000269|PubMed:11809800, ECO:0000269|PubMed:11884399, ECO:0000269|PubMed:12037670, ECO:0000269|PubMed:14701750, ECO:0000269|PubMed:15564463, ECO:0000269|PubMed:16109376, ECO:0000269|PubMed:16109377, ECO:0000269|PubMed:17956865, ECO:0000269|PubMed:18362169, ECO:0000269|PubMed:19575011, ECO:0000269|PubMed:19844166, ECO:0000269|PubMed:20081228, ECO:0000269|PubMed:20493174, ECO:0000269|PubMed:20930849, ECO:0000269|PubMed:20980437, ECO:0000269|PubMed:21127351, ECO:0000269|PubMed:28426094, ECO:0000269|PubMed:9857195}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CDK9-CDK9 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for CDK9-CDK9 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CDK9-CDK9 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CDK9-CDK9 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies